Genetic polymorphisms in chronic hyperplastic sinusitis with nasal polyposis

Laryngoscope

Volumn 119, Issue 7, 2009, Pages 1258-1264

  Bernstein, Joel M ^a,f   Anon, Jack B ^b   Rontal, Michael ^c   Conroy, Jeffrey ^d   Wang, Chong ^e   Sucheston, Lara ^d,e  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

^e UNIVERSITY AT BUFFALO   (United States)

^f NONE   (United States)

Author keywords

Chronic inflammation; Genes; Nasal polyps; Single nucleotide polymorphism; Tumor necrosis factor 308

Indexed keywords

CD14 ANTIGEN; CYTOKINE; DNA; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CHRONIC SINUSITIS; CONTROLLED STUDY; DNA PURIFICATION; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HYPERPLASIA; MAJOR CLINICAL STUDY; MALE; MOUTH MUCOSA; NOSE POLYP; PRIORITY JOURNAL;

EID: 67949121728     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.20239     Document Type: Article

References (33)

1. Feezor RJ, Moldawer LL. Genetic polymorphisms, functional genomics and the host inflammatory response to injury and inflammation. In: Cynober L., Moore FA, eds. Nutrition and Critical Care. Vol. 8. Basel, Switzerland: Karger AG; 2003:15-37.
2. Bone RC. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and what we do not know about cytokine regulation. Crit Care Med 1996; 24:163-172.
3. Hollaway AF, Rao S., Shannon MF. Regulation of cytokine gene transcription in the immune system. Mol Immunol 2002; 38:567-580.
4. Bernstein JM. The molecular biology of nasal polyposis. Curr Allergy Asthma Rep 2001;l:262-267.
5. Wang X., Dong Z., Zhu DD, Guan B. Expression profile of immune-associated genes in nasal polyps. Ann Otol Rhinol Laryngol 2006; 115:450-456.
6. Kratka Z., Bartoba J., Krejsa O., Otcenaskova M., Janatova T., Duskova J. Interleukin-1 gene polymorphisms as assessed in a 10-year study of patients with early-onset periodontitis. Folia Microbiol 2007; 52:183-188.
7. Sykora J., Subrit I., Didek P., et al. Cytokine tumor necrosis factor-α promoter gene polymorphism at position -308 G → A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease. J Pediatr Gastroenterol Nutr 2006; 42:479-487.
8. Dong LM, Potter JD, White E., Ulrich CM, Cardon LR, Peters U. Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA 2008; 299: 2423-2436.
9. Texereau J., Chiche JD, Taylor W., Choukroun G., Comba B., Mira JP The importance of Toll-like receptor 2 polymorphisms in severe infections. Clin Infect Dis 2005; 41 (suppl 7) :S408-S415.
10. Joki-Erkkila VP, Puhakka H., Hurme M. Cytokine gene polymorphism in recurrent acute otitis media. Arch Otolaryngol Head Neck Surg 2002; 128:17-20.
11. Karjalainen J., Joki-Erkkila VP, Hulkkonen J., et al. The IL-1A genotype is associated with nasal polyposis in asthmatic adults. Allergy 2003; 58:393-396.
12. Cheng YK, Der Lin C., Chang WC, et al. Increased prevalence of interleukin-1 receptor antagonist gene polymorphism in patients with chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg 2006; 132:285-290.
13. Erbeck SS, Yurtcu E., Erbek S., Belginatac F., Sahin FI, Cakmak O. Pro-inflammatory cytokine single nucleotide polymorphisms in nasal polyposis. Arch Otolaryngol Head Neck Surg 2007; 133:705-709.
14. de Alarcon A., Steinke JW, Caughey R., et al. Expression of leukotriene C4 synthase and plasminogen activator inhibitor 1 gene promoter polymorphisms in sinusitis. Am J Rhinol 2006; 20:545-549.
15. Wang LF, Chien CY, Kuo WR, Tai CF, Juo SH. Matrix metalloproteinase-2 gene polymorphisms in nasal polyps. Arch Otolaryngol Head and Neck Surg 2008; 134:852-856.
16. Gaskins RE. A surgical staging system for chronic sinusitis. Am J Rhinol 1992; 6:5-12.
17. Lund VJ, MacKay IS. Staging in rhinosinusitis. Rhinology 1993; 31:183-184.
18. Kang K., Fu DJ, Julien D., Braun A., Cantor CR, Koster H. Chip-based genotyping by mass spectrometry. Proc Natl Acad Sci USA 1999; 96:10016-10020.
19. Trikalinos TA, Salanti G., Khoury MJ, Ioannidis JP Impact of violations and deviations in Hardy-Weinberg Equilibrium on postulated gene-disease associations. Am J Epidemiol 2006; 163;300-309.
20. Armitage P. Test for linear trends in proportions and frequencies. Biometrics 1955;ll:375-386.
21. Cochran WG. Some methods for strengthening the common chi-squared tests. Biometrics 1954; 10:417-451.
22. Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor-α promoter polymorphism effects transcription. Mol Immunol 1997; 34:391-399.
23. Wilson AG, Symons J., McDowell TL, McDebitt HO. Effects of a polymorphism in the human tumor necrosis factor-α promoter on transcription activation. Proc Natl Acad Sci USA 1997; 94:3195-3199.
24. Collins MM, Pang YT, Loughran S., Wilson JA. Environmental risk factors and gender in nasal polyposis. Clin Otolaryngol Allied Sci 2002; 27:314-317.
25. Busaba NY, Sin HJ, Salman SD. Impact of gender on clinical presentation of chronic rhinosinusitis with and without polyposis. J Laryngol Otol 2008; 122:1180-1184.
26. Lieu ZZ, Lock JG, Hammond LA, La Gruta NL, Stow JL, Gleeson PA. A trans-Golgi network golgin is required for the regulated secretion of TNF in activated macrophages in vivo. Proc Natl Acad Sci U S A 2008; 105:3351-3356.
27. Komorowska A., Komorowski J., Banasik M., Lewkowicz P., Tchorzewski H. Cytokines locally produced by lymphocytes removed from the hypertrophic nasopharyngeal and palatine tonsils. Int J Pediatr Otorhinolaryngol 2005; 69: 937-941.
28. Tracey D., Klareskog L., Sasso EH, Salfeld GG, Gak PP. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther 2008; 117:244-279.
29. Ohori J., Ushikai M., Sun D., et al. TNF-α upregulates VCAM-1 and NF-κB in fibroblasts from nasal polyps. Auris Nasus Larynx 2007; 34:177-183.
30. Jahnsen FL, Brandtzaeg P., Haye R., Haraldsen G. Expression of functional VCAM-1 by cultured nasal polyp derived microvascular endothelium. Am J Pathol 1997; 150:2113-2123.
31. Finotto S., Ohno I., Marshall JS, et al. TNF-α production by eosinophils in upper airways inflammation (nasal polyposis). J Immunol 1994; 153:2278-2289.
32. Yoshifuku K., Matsune S., Ohori J., Sagara Y., Fukuwa T., Kurono Y. IL-4 and TNF-α increased the secretion of eotaxin from cultured fibroblasts of nasal polyps with eosinophil infiltration. Rhinology 2007; 45:235-241.
33. Sajai F., Nonaka M., Pawankar R. Expression of RANTES by IL-1β and TNF-α stimulated nasal polyp fibroblasts. Auris Nasus Larynx 2000; 27:247-252.